Literature DB >> 19726670

A novel function of heparan sulfate in the regulation of cell-cell fusion.

Christopher D O'Donnell1, Deepak Shukla.   

Abstract

Despite the important contribution of cell-cell fusion in the development and physiology of eukaryotes, little is known about the mechanisms that regulate this process. Our study shows that glycosaminoglycans and more specifically heparan sulfate (HS) expressed on the cell surface and extracellular matrix may act as negative regulator of cell-cell fusion. Using herpes simplex virus type-1 as a tool to enhance cell-cell fusion, we demonstrate that the absence of HS expression on the cell surface results in a significant increase in cell-cell fusion. An identical phenomenon was observed when other viruses or polyethylene glycol was used as fusion enhancer. Cells deficient in HS biosynthesis showed increased activity of two Rho GTPases, RhoA and Cdc42, both of which showed a correlation between increased activity and increased cell-cell fusion. This could serve as a possible explanation as to why HS-deficient cells showed significantly enhanced cell-cell fusion and suggests that HS could regulate fusion via fine tuning of RhoA and Cdc42 activities.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19726670      PMCID: PMC2785597          DOI: 10.1074/jbc.M109.037960

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  86 in total

Review 1.  Regulation of cytoskeletal organization by syndecan transmembrane proteoglycans.

Authors:  Atsuko Yoneda; John R Couchman
Journal:  Matrix Biol       Date:  2003-03       Impact factor: 11.583

Review 2.  Forming a multinucleated cell: molecules that regulate myoblast fusion.

Authors:  Valerie Horsley; Grace K Pavlath
Journal:  Cells Tissues Organs       Date:  2004       Impact factor: 2.481

3.  Fusion of cells by flipped SNAREs.

Authors:  Chuan Hu; Mahiuddin Ahmed; Thomas J Melia; Thomas H Söllner; Thomas Mayer; James E Rothman
Journal:  Science       Date:  2003-06-13       Impact factor: 47.728

Review 4.  Plasticity of adult stem cells.

Authors:  Amy J Wagers; Irving L Weissman
Journal:  Cell       Date:  2004-03-05       Impact factor: 41.582

Review 5.  Herpesvirus entry: an update.

Authors:  Patricia G Spear; Richard Longnecker
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

Review 6.  Differentiation and function of osteoclasts.

Authors:  Takeshi Miyamoto; Toshio Suda
Journal:  Keio J Med       Date:  2003-03

7.  Mutations in the N termini of herpes simplex virus type 1 and 2 gDs alter functional interactions with the entry/fusion receptors HVEM, nectin-2, and 3-O-sulfated heparan sulfate but not with nectin-1.

Authors:  Miri Yoon; Anna Zago; Deepak Shukla; Patricia G Spear
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

8.  Hybrid-cell vaccines for cancer immune therapy.

Authors:  Uwe Trefzer; Peter Walden
Journal:  Mol Biotechnol       Date:  2003-09       Impact factor: 2.695

9.  Neuraminidase treatment of respiratory syncytial virus-infected cells or virions, but not target cells, enhances cell-cell fusion and infection.

Authors:  Naina Barretto; Louay K Hallak; Mark E Peeples
Journal:  Virology       Date:  2003-08-15       Impact factor: 3.616

10.  Tetraspanins CD9 and CD81 function to prevent the fusion of mononuclear phagocytes.

Authors:  Yoshito Takeda; Isao Tachibana; Kenji Miyado; Masatoshi Kobayashi; Toru Miyazaki; Toshiki Funakoshi; Hiromi Kimura; Hiroyuki Yamane; Yoshiyuki Saito; Hiroyuki Goto; Tsutomu Yoneda; Mitsuhiro Yoshida; Toru Kumagai; Tadashi Osaki; Seiji Hayashi; Ichiro Kawase; Eisuke Mekada
Journal:  J Cell Biol       Date:  2003-06-09       Impact factor: 10.539

View more
  17 in total

1.  Rapid fusion and syncytium formation of heterologous cells upon expression of the FGFRL1 receptor.

Authors:  Florian Steinberg; Simon D Gerber; Thorsten Rieckmann; Beat Trueb
Journal:  J Biol Chem       Date:  2010-09-17       Impact factor: 5.157

2.  Mediators and mechanisms of herpes simplex virus entry into ocular cells.

Authors:  Asim V Farooq; Tibor Valyi-Nagy; Deepak Shukla
Journal:  Curr Eye Res       Date:  2010-06       Impact factor: 2.424

3.  Anti-heparan sulfate peptides that block herpes simplex virus infection in vivo.

Authors:  Vaibhav Tiwari; Jian Liu; Tibor Valyi-Nagy; Deepak Shukla
Journal:  J Biol Chem       Date:  2011-05-19       Impact factor: 5.157

4.  A 3-O-sulfated heparan sulfate binding peptide preferentially targets herpes simplex virus 2-infected cells.

Authors:  Mohamed M Ali; Ghadah A Karasneh; Min Jung Jarding; Vaibhav Tiwari; Deepak Shukla
Journal:  J Virol       Date:  2012-04-04       Impact factor: 5.103

5.  Virostatic potential of micro-nano filopodia-like ZnO structures against herpes simplex virus-1.

Authors:  Yogendra Kumar Mishra; Rainer Adelung; Claudia Röhl; Deepak Shukla; Frank Spors; Vaibhav Tiwari
Journal:  Antiviral Res       Date:  2011-08-26       Impact factor: 5.970

6.  Prophylactic, therapeutic and neutralizing effects of zinc oxide tetrapod structures against herpes simplex virus type-2 infection.

Authors:  Thessicar E Antoine; Yogendra K Mishra; James Trigilio; Vaibhav Tiwari; Rainer Adelung; Deepak Shukla
Journal:  Antiviral Res       Date:  2012-10-06       Impact factor: 5.970

Review 7.  Viral entry mechanisms: cellular and viral mediators of herpes simplex virus entry.

Authors:  Jihan Akhtar; Deepak Shukla
Journal:  FEBS J       Date:  2009-12       Impact factor: 5.542

8.  Examination of soluble integrin resistant mutants of foot-and-mouth disease virus.

Authors:  Paul Lawrence; Michael LaRocco; Barry Baxt; Elizabeth Rieder
Journal:  Virol J       Date:  2013-01-02       Impact factor: 4.099

9.  Members of 3-O-Sulfotransferases (3-OST) Family: A Valuable Tool from Zebrafish to Humans for Understanding Herpes Simplex Virus Entry.

Authors:  John Baldwin; Deepak Shukla; Vaibhav Tiwari
Journal:  Open Virol J       Date:  2013-01-21

10.  Tin oxide nanowires suppress herpes simplex virus-1 entry and cell-to-cell membrane fusion.

Authors:  James Trigilio; Thessicar E Antoine; Ingo Paulowicz; Yogendra K Mishra; Rainer Adelung; Deepak Shukla
Journal:  PLoS One       Date:  2012-10-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.